Follow us on Facebook!
Follow us on Twitter!
Follow us on Youtube!
News archive

 

Myeloma Patients Europe (MPE) will hold a webinar on reimbursement and Health Technology Assessment (HTA) on Wednesday 18 March 2020 from 18:00 – 19:00 CET.

The webinar will be given by Neil Bertelsen, Steering Committee member at Health Technology Assessment International (HTAi), who will give a 40-minute presentation on the concepts of reimbursement, health technology assessment and patient involvement in decision-making. The session will be followed by a 20-minute Q&A session.

This webinar is part of the webinar series planned to replace the MPE Annual General Meeting (AGM), which was cancelled due to the outbreak of the coronavirus infection.

Registration is free of charge. Feel free to forward the registration link to colleagues and other patient advocates who might be interested in attending the webinar.

Should you be unable to attend the webinar, please feel free to send your questions in advance to info@mpeurope.org and we will make sure they reach our speaker.

A recording of the webinar will be available shortly after the session.

We look forward to your participation.

 

 

Check below the list of webinars and register now:

Topic Speaker Date and time Link to register
Webinar on big data in haematology, the Harmony example Ana Rodríguez, Institute of Cancer Molecular and Biology (USAL-CSIC), Salamanca, Spain Thursday 2 April
(18:00 – 19:00 CET)
Webinar on Minimal Residual Disease (MRD) in myeloma and related diseases Paula van Hennik, Committee for Medicinal Products for Human Use (CHMP) member at the European Medicine Agency (EMA) Monday 20 April
(18:00 – 19:00 CET)
Webinar on personalised medicines in myeloma and AL amyloidosis Dr Francesca Bonello, Università degli Studi di Torino Monday 6 May
(18:00 – 19:00 CET)
Webinar on how to develop patient materials Alice Baron, Information Manager at Myeloma UK (MUK) 30 June
(18:00 – 19:00 CET)

 

Leave a Reply

Your email address will not be published. Required fields are marked *